Management of Librium (Chlordiazepoxide) Overdose

Initial Assessment and Management

The American Heart Association recommends establishing and maintaining an open airway as the first priority, providing bag-mask ventilation for respiratory depression, followed by endotracheal intubation when appropriate 1, 2
Contacting a regional poison center for expert guidance in management is crucial 3

The American College of Cardiology suggests providing respiratory support as needed, which is the cornerstone of management for benzodiazepine overdose 1, 2
Monitoring for hypoxemia and hypercarbia is essential, as they are the primary causes of tissue injury and death in benzodiazepine overdose 1

Flumazenil may be considered in select patients with respiratory depression/arrest caused by pure benzodiazepine poisoning who do not have contraindications 4
The initial adult dose of flumazenil is 0.2 mg IV, titrated up to 1 mg, and the pediatric dose is 0.01 mg/kg 1
The American Academy of Clinical Toxicology recommends avoiding flumazenil in patients with benzodiazepine dependence, history of seizure disorders, suspected co-ingestion of tricyclic/tetracyclic antidepressants, co-ingestion of other seizure-threshold lowering drugs, and hypoxia 1, 2, 4

If combined opioid and benzodiazepine poisoning is suspected, administering naloxone first before considering other antidotes for respiratory depression is recommended 4
Monitoring for resedation is crucial, as the duration of action of flumazenil may be shorter than that of chlordiazepoxide 5
Considering the possibility of multiple drug ingestion is essential, as it is common in overdose scenarios 1, 3

Failing to recognize mixed overdoses, especially with opioids or alcohol, can lead to inadequate treatment 1, 6
Administering flumazenil to patients with benzodiazepine dependence or co-ingestion of tricyclic antidepressants can precipitate severe reactions 1, 2
Assuming flumazenil will fully reverse respiratory depression, particularly in mixed overdoses, can lead to inadequate respiratory support 1
Neglecting to provide adequate respiratory support while focusing on pharmacological interventions can result in poor patient outcomes 1, 2